Translation News and Research

RSS
MIIR partners with international biosciences to develop potential anti-cancer drugs

MIIR partners with international biosciences to develop potential anti-cancer drugs

Baxter International acquires drug candidate developed to treat sickle cell disease

Baxter International acquires drug candidate developed to treat sickle cell disease

HD Biosciences and MIIR partner to co-develop potential anti-cancer drugs

HD Biosciences and MIIR partner to co-develop potential anti-cancer drugs

American Pain Society, Pain Research Forum provide grant support for PRF's "Papers of the Week"

American Pain Society, Pain Research Forum provide grant support for PRF's "Papers of the Week"

Investigators discover novel cellular genes by uncovering uncharacterized RNAs that encode proteins

Investigators discover novel cellular genes by uncovering uncharacterized RNAs that encode proteins

CBT reduces urge to obey command hallucinations

CBT reduces urge to obey command hallucinations

Innovative device boosts tooth's natural repair process

Innovative device boosts tooth's natural repair process

NSF awards nearly $200,000 to make environmentally friendly field analyzer

NSF awards nearly $200,000 to make environmentally friendly field analyzer

Scientists discover important new biomarker that could improve HER2 targeted cancer treatments

Scientists discover important new biomarker that could improve HER2 targeted cancer treatments

Professor opens new University of Leicester British Heart Foundation CRC on 11 June 2014

Professor opens new University of Leicester British Heart Foundation CRC on 11 June 2014

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Elekta and Philips partner to develop integrated MRI guided radiation therapy system

Elekta and Philips partner to develop integrated MRI guided radiation therapy system

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

NYU Langone scientists identify promising treatment target for Alzheimer's disease

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

New approach could lead to more effective HIV vaccine

New approach could lead to more effective HIV vaccine

Noninvasive laser therapy triggers stem cells to repair enamel of teeth

Noninvasive laser therapy triggers stem cells to repair enamel of teeth

Study: Sufficient copies of SMN1 gene extend survival in animals with spinal muscular atrophy

Study: Sufficient copies of SMN1 gene extend survival in animals with spinal muscular atrophy

New compound restores learning, memory and other symptoms of AD in mice

New compound restores learning, memory and other symptoms of AD in mice

New drug offers promising possibility for treating adults with periodontitis

New drug offers promising possibility for treating adults with periodontitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.